719 related articles for article (PubMed ID: 35810138)
1. Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117].
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U;
Ann Oncol; 2022 Sep; 33(9):988. PubMed ID: 35810138
[No Abstract] [Full Text] [Related]
2. Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U;
Ann Oncol; 2022 Jan; 33(1):117. PubMed ID: 34857439
[No Abstract] [Full Text] [Related]
3. Corrigendum to 'Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Annals of Oncology Volume 31, Issue 6, June 2020, Pages 697-712].
Heuser M; Ofran Y; Boissel N; Brunet Mauri S; Craddock C; Janssen J; Wierzbowska A; Buske C;
Ann Oncol; 2021 Jun; 32(6):821. PubMed ID: 33888380
[No Abstract] [Full Text] [Related]
4. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U; ;
Ann Oncol; 2021 Mar; 32(3):309-322. PubMed ID: 33549387
[No Abstract] [Full Text] [Related]
5. Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U
Hemasphere; 2021 Feb; 5(2):e528. PubMed ID: 33554050
[No Abstract] [Full Text] [Related]
6. Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
Hemasphere; 2021 Dec; 5(12):e659. PubMed ID: 34859196
[TBL] [Abstract][Full Text] [Related]
7. Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
Hemasphere; 2021 Apr; 5(4):e567. PubMed ID: 33824948
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022].
van Herpen C; Vander Poorten V; Skalova A; Terhaard C; Maroldi R; van Engen A; Baujat B; Locati LD; Jensen AD; Smeele L; Hardillo J; Costes Martineau V; Trama A; Kinloch E; Even C; Machiels JP;
ESMO Open; 2023 Oct; 8(5):101630. PubMed ID: 37625197
[No Abstract] [Full Text] [Related]
9. Corrigendum to "ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe": Ann Oncol 2016; 27 (8): 1423-1443.
Cherny N; Sullivan R; Torode J; Saar M; Eniu A
Ann Oncol; 2020 Nov; 31(11):1589. PubMed ID: 32958358
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490].
Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;
Ann Oncol; 2023 Jul; 34(7):631. PubMed ID: 36564283
[No Abstract] [Full Text] [Related]
11. EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes.
van de Loosdrecht AA; Mandac Smoljanović I
Hemasphere; 2022 Mar; 6(3):e695. PubMed ID: 35233507
[No Abstract] [Full Text] [Related]
12. EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström's Macroglobulinemia.
Staber PB; Kersten MJ
Hemasphere; 2021 Oct; 5(10):e634. PubMed ID: 34522842
[No Abstract] [Full Text] [Related]
13. EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia.
Eichhorst B; Ghia P
Hemasphere; 2021 Jan; 5(1):e520. PubMed ID: 33403356
[No Abstract] [Full Text] [Related]
14. Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ferreri AJM; Illerhaus G; Doorduijn JK; Auer DP; Bromberg JEC; Calimeri T; Cwynarski K; Fox CP; Hoang-Xuan K; Malaise D; Ponzoni M; Schorb E; Soussain C; Specht L; Zucca E; Buske C; Jerkeman M; Dreyling M;
Hemasphere; 2024 Jun; 8(6):e89. PubMed ID: 38836097
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288.
Bjelic-Radisic V; Cardoso F; Cameron D; Brain E; Kuljanic K; da Costa RA; Conroy T; Inwald EC; Serpentini S; Pinto M; Weis J; Morag O; Lindviksmoen Astrup G; Tomaszewski KA; Pogoda K; Sinai P; Sprangers M; Aaronson N; Velikova G; Greimel E; Arraras J; Bottomley A;
Ann Oncol; 2020 Apr; 31(4):552. PubMed ID: 32089397
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 32 (2021) 439-451].
Baudin E; Caplin M; Garcia-Carbonero R; Fazio N; Ferolla P; Filosso PL; Frilling A; de Herder WW; Hörsch D; Knigge U; Korse CM; Lim E; Lombard-Bohas C; Pavel M; Scoazec JY; Sundin A; Berruti A;
Ann Oncol; 2021 Nov; 32(11):1453-1455. PubMed ID: 34598840
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29].
Zucca E; Arcaini L; Buske C; Johnson PW; Ponzoni M; Raderer M; Ricardi U; Salar A; Stamatopoulos K; Thieblemont C; Wotherspoon A; Ladetto M;
Ann Oncol; 2023 Mar; 34(3):325. PubMed ID: 36529567
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255].
Vogel A; Cervantes A; Chau I; Daniele B; Llovet JM; Meyer T; Nault JC; Neumann U; Ricke J; Sangro B; Schirmacher P; Verslype C; Zech CJ; Arnold D; Martinelli E;
Ann Oncol; 2022 Jun; 33(6):666. PubMed ID: 35365377
[No Abstract] [Full Text] [Related]
19. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care.
Jordan K; Aapro M; Kaasa S; Ripamonti CI; Scotté F; Strasser F; Young A; Bruera E; Herrstedt J; Keefe D; Laird B; Walsh D; Douillard JY; Cervantes A
Ann Oncol; 2018 Jan; 29(1):36-43. PubMed ID: 29253069
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum to "European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO" [Eur J Surg Oncol 50 (1) (January 2024) 107292].
Rubio IT; Wyld L; Marotti L; Athanasiou A; Regitnig P; Catanuto G; Schoones JW; Zambon M; Camps J; Santini D; Dietz J; Sardanelli F; Varga Z; Smidt M; Sharma N; Shaaban AM; Gilbert F
Eur J Surg Oncol; 2024 Mar; 50(3):107943. PubMed ID: 38246851
[No Abstract] [Full Text] [Related]
[Next] [New Search]
